Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3033093	y.ent9abm	— (—)	55	55	100.00%	Distribution not available
3033093	y.ent3abm	— (—)	54	54	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Arthropathies

8.55

12.07

2.0

1.9

—

Used for control exclusion in common control thyroid runs

5.46

10.25

2.0

—

Other specified/unspecified arthritis

18.59

8.92

2.0

—

Any gastric operation

6.45

8.13

2.0

1.9

—

GASTRO-related operations

6.45

8.13

2.0

1.9

—

Other specific joint derangements/joint disorders

8.83

7.62

2.0

1.9

—

Finngen Rheumatological endpoints

5.13

7.52

2.0

—

Polyarthropathies

9.34

7.46

2.0

1.9

—

Autoimmune diseases

4.32

7.27

2.0

—

Autoimmune diseases related-to ILD

4.42

7.07

2.0

—

Other arthritis (FG)

8.76

7.03

2.0

—

Other joint disorders

7.22

6.90

2.0

1.9

—

ILD medications

4.35

6.88

2.0

—

General symptoms and signs

4.38

6.72

2.0

—

Chronic diseases of tonsils and adenoids

4.05

5.81

2.0

—

Inflammatory bowel disease treatment related agents

3.82

5.73

2.0

—

Oral corticosteroids

4.06

5.66

2.0

—

Any reimbursement code in KELA

6.84

5.60

2.0

—

Pain in joint

6.61

5.44

2.0

1.9

—

Diseases of the skin and subcutaneous tissue

3.93

5.13

2.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.94

5.07

2.0

—

Headache

5.04

5.05

2.0

—

Endocrine, nutritional and metabolic diseases

3.79

4.93

2.0

—

Certain infectious and parasitic diseases

3.61

4.64

2.0

—

Arthrosis

6.57

4.59

2.0

1.9

—

Parasetamol

5.44

4.59

2.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.42

4.24

2.0

—

Autoimmune diseases excluding thyroid diseases

3.41

4.21

2.0

—

First line medication for Crohn's disease

3.39

4.16

2.0

—

Internal derangement of knee

7.92

4.03

2.0

—

Genitourinary diseases

6.13

3.99

2.0

—

ILD medications: immunosuppressive drugs

4.53

3.93

2.0

—

Other diseases of upper respiratory tract

3.12

3.90

2.0

—

Opioids

3.25

3.89

2.0

—

Other pulmonary diagnosis

3.69

3.74

2.0

—

COPD/asthma/ILD related infections

3.15

3.69

2.0

—

COPD/asthma related infections

3.15

3.69

2.0

—

Second line medication for Crohn's disease

3.71

3.58

2.0

—

Inflammatory bowel disease

4.76

3.55

2.0

—

Diseases of middle ear and mastoid

4.08

3.54

2.0

—

Diseases of the musculoskeletal system and connective tissue

5.02

3.51

2.0

1.9

—

Codeine

3.24

3.49

2.0

—

Soft tissue disorders

3.00

3.47

2.0

—

Cardiovascular diseases

3.38

3.42

2.0

—

Codeine or tramadol medication

2.88

3.33

2.0

—

Diseases of the respiratory system

4.59

3.29

2.0

1.9

—

Budesonide

8.58

3.26

2.0

—

Cardiovascular diseases (excluding rheumatic etc)

3.23

3.08

2.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.70

3.03

1.9

2.0

—

Tonsillectomy and adenotomy

3.48

2.98

2.0

—

Noninfective enteritis and colitis

3.84

2.97

2.0

—

External causes of morbidity and mortality

3.94

2.92

2.0

1.9

—

Noninflammatory disorders of female genital tract

7.03

2.90

2.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.75

2.87

1.9

2.0

—

Caries of dentine, including avohilmo

3.75

2.81

2.0

—

Medical observation and evaluation for suspected diseases and conditions

3.75

2.81

2.0

—

Pain in limb

2.95

2.79

2.0

—

Chronic laryngitis and laryngotracheitis

8.34

2.75

2.0

—

Dental operations

3.96

2.72

2.0

1.9

—

L04AX Other immunosuppressants

3.23

2.72

2.0

—

Gastro-oesophageal reflux disease

3.07

2.69

2.0

—

Anxiety disorders, excluding more controls

2.86

2.67

2.0

—

COPD differential diagnosis

3.16

2.65

2.0

—

ILD differential diagnosis

3.16

2.65

2.0

—

Excluding asthma or asthma-COPD overlap

3.16

2.65

2.0

—

Pain (limb, back, neck, head abdominally)

3.85

2.65

2.0

1.9

—

Tramadol

3.00

2.62

2.0

—

Diseases of pulp and periapical tissues and dental caries

4.20

2.61

2.0

—

Crohn disease

5.46

2.54

2.0

—

Artrosis, including avohilmo

2.85

2.53

2.0

—

Other bacterial diseases, including avohilmo

2.53

2.48

2.0

—

Hypertensive diseases (excluding secondary)

3.20

2.48

2.0

—

Other external causes of accidental injury

3.01

2.47

2.0

—

Accidents

3.01

2.47

2.0

—

Symptoms and signs involving the circulatory and respiratory systems

2.59

2.44

2.0

—

Other arthrosis

4.69

2.43

2.0

1.9

—

5-aminosalicylic acid

5.00

2.40

2.0

—

Benign neoplasm: Colon

3.38

2.40

2.0

—

Neurotic, stress-related and somatoform disorders

2.54

2.40

2.0

—

Injury, poisoning and certain other consequences of external causes

3.76

2.38

2.0

1.9

—

Infections of the skin and subcutaneous tissue

2.98

2.30

1.9

2.0

—

Other soft tissue disorders, not elsewhere classified

2.64

2.27

2.0

—

Anxiety disorders

2.46

2.27

2.0

—

IBD patients in KELA-register

3.89

2.25

2.0

—

Inflammatory bowel disease, strict (require KELA)

3.89

2.25

2.0

—

Obstructed labour due to maternal pelvic abnormality

5.56

2.21

2.0

—

Ulcerative colitis, NAS

5.56

2.21

2.0

—

Diseases of the ear and mastoid process

2.36

2.19

2.0

—

Other diseases of hard tissues of teeth

3.77

2.18

2.0

—

Diseases of oral cavity, salivary glands and jaws

3.75

2.17

2.0

—

Dental caries, including avohilmo

3.29

2.12

2.0

—

Hypothyroidism, levothyroxine purchases

4.80

2.10

2.0

—

Hypothyroidism and >3 levothyroxin purchases

4.80

2.10

2.0

—

Hypothyroidism (congenital or acquired)

4.80

2.10

2.0

—

Gonarthrosis

3.95

2.08

2.0

1.9

—

Impingement syndrome of shoulder

5.00

2.07

2.0

—

Disorders of skin appendages

2.89

2.05

2.0

—

Diagnoses used for exclusion with ILD

4.00

2.04

1.8

2.0

—

Benign neoplasms

2.38

2.01

2.0

—

Diseases of male genital organs

3.92

2.01

2.0

—

Obesity due to excess calories

3.08

2.01

2.0

—

Psychiatric diseases

2.50

2.01

2.0

—

Other diseases of intestines

2.36

2.00

2.0

—

Intestinal infectious diseases

2.36

1.99

2.0

—

Low back pain

2.45

1.94

2.0

—

Psoriasis vulgaris

4.55

1.94

2.0

—

Irritable bowel syndrome

3.75

1.93

2.0

—

Fever of other and unknown origin

3.01

1.93

2.0

—

Excessive, frequent and irregular menstruation

5.34

1.91

2.0

—

Other bacterial diseases

2.33

1.89

2.0

—

Acute upper respiratory infections

2.27

1.88

2.0

—

Benign neoplasm of colon, rectum, anus and anal canal

2.72

1.88

2.0

—

Neoplasms

2.62

1.88

2.0

—

Acute sinusitis

2.91

1.87

2.0

—

Diabetes, varying definitions

2.25

1.85

1.9

2.0

—

Diabetes mellitus

2.24

1.83

1.9

2.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

4.17

1.82

2.0

—

Fracture of skull and facial bones

4.17

1.82

2.0

—

Hallux valgus (acquired)

4.47

1.82

2.0

1.9

—

Hypothyroidism, strict autoimmune

2.68

1.79

2.0

—

Other systemic involvement of connective tissue (FG)

4.09

1.79

2.0

—

Diseases of pulp and periapical tissues, including avohilmo

2.32

1.77

2.0

—

Type 2 diabetes, definitions combined, including avohilmo

2.28

1.76

1.9

2.0

—

Dislocation, sprain and strain of joints and ligaments of knee

2.54

1.75

2.0

—

Ulcerative colitis

3.33

1.74

2.0

—

Supervision of high-risk pregnancy

4.29

1.71

2.0

—

Coxarthrosis [arthrosis of hip](FG)

3.44

1.70

2.0

—

Gastrointestinal diseases

2.64

1.69

2.0

1.9

—

Disorders of other endocrine glands

2.87

1.69

2.0

—

Antihypertensive medication - note that there are other indications

2.61

1.68

2.0

—

Injuries to the head

2.13

1.65

2.0

—

Symptoms and signs involving the digestive system and abdomen

2.25

1.65

2.0

—

Falls/tendency to fall

2.24

1.65

2.0

—

General examination and investigation of persons without complaint and reported diagnosis

2.77

1.64

2.0

—

Sulfasalazine

3.57

1.61

2.0

—

Appendectomy

2.38

1.61

2.0

—

Exclusions for E4_PCOS_CONSORTIUM

2.29

1.54

2.0

—

Any mental disorder

2.17

1.54

2.0

—

Substance abuse, excluding more controls

2.66

1.52

2.0

—

Benign neoplasm: Colon, unspecified

3.33

1.52

2.0

—

Rotator cuff syndrome

2.58

1.52

2.0

—

Conjunctivitis (acute, non atopic)

2.84

1.49

2.0

—

Dizziness and giddiness

2.29

1.48

2.0

—

Reimbursement for rheumatic diseases

2.42

1.47

2.0

—

Atopic dermatitis

2.39

1.45

2.0

—

Suppurative and unspecified otitis media

2.80

1.45

2.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.36

1.45

2.0

—

Factors influencing health status and contact with health services

3.59

1.44

2.0

—

Dorsalgia

2.09

1.44

2.0

—

Primary coxarthrosis, bilateral

3.13

1.44

2.0

—

Examination and observation for other reasons

2.63

1.43

2.0

—

Shoulder lesions

2.30

1.42

2.0

—

Other disorders of skin and subcutaneous tissue

2.22

1.41

2.0

—

Abnormal findings on diagnostic imaging of lung

2.71

1.41

2.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.70

1.38

2.0

—

Oxycodone

3.05

1.38

2.0

—

Disease of hard tissues of teeth, NOS

2.85

1.37

2.0

—

Papulosquamous disorders

2.61

1.36

2.0

—

Primary gonarthrosis, bilateral

2.64

1.36

2.0

—

Diabetes medication

2.00

1.34

1.9

2.0

—

Other nutritional deficiencies

2.16

1.34

2.0

—

Lower back pain or/and sciatica

1.97

1.31

2.0

—

Meniscus derangement

3.02

1.31

2.0

1.9

—

Abdominal and pelvic pain

2.08

1.31

2.0

—

Dermatitis and eczema

1.97

1.31

2.0

—

Injuries to the neck

2.50

1.30

2.0

—

Episodal and paroxysmal disorders

2.00

1.30

2.0

—

Other dorsopathies, not elsewhere classified

1.99

1.29

2.0

—

Complications of surgical and medical care, not elsewhere classified

2.00

1.28

2.0

—

Psoriasis

2.78

1.28

2.0

—

Diverticular disease of intestine

2.37

1.28

2.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.16

1.24

2.0

—

2.16

1.24

2.0

—

Depression or dysthymia

2.30

1.24

2.0

—

Urticaria and erythema

2.40

1.24

1.8

2.0

—

Maternal care for known or suspected abnormality of pelvic organs

2.81

1.23

2.0

1.9

—

Viral and other specified intestinal infections, including avohilmo

2.67

1.23

2.0

—

Statin medication

2.06

1.22

2.0

—

Persons encountering health services in other circumstances

2.37

1.22

2.0

—

Sleep disorders (combined)

1.94

1.22

2.0

—

1.94

1.21

2.0

—

Dorsopathies

1.94

1.21

2.0

—

Osteopathies and chondropathies

2.15

1.20

2.0

—

Conjunctivitis (acute, non atopic), including avohilmo

1.96

1.20

2.0

—

Bacterial Sepsis

2.36

1.19

2.0

—

Disorders of conjunctiva

1.98

1.19

2.0

—

Pain in throat and chest

2.11

1.19

1.9

2.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.93

1.19

2.0

—

Acute suppurative otitis media

2.59

1.18

2.0

—

Obesity

2.09

1.17

2.0

—

Obesity and other hyperalimentation

2.09

1.17

2.0

—

Atopic dermatitis, strict definition with reimbursement

2.53

1.16

2.0

—

Hypertensive diseases

2.00

1.14

2.0

—

Hypertension

2.00

1.14

2.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.05

1.14

2.0

—

Exposure to unspecified factor

1.90

1.14

2.0

—

Fall on same level

1.87

1.13

2.0

—

Gonarthrosis [arthrosis of knee](FG)

2.37

1.12

2.0

1.9

—

Persons encountering health services for examination and investigation

2.34

1.11

2.0

—

Irregular menses

2.28

1.10

2.0

—

Pneumonia, organism unspecified

1.93

1.10

2.0

—

Other and unspecified tonsillitis

2.44

1.10

2.0

—

Symptoms and signs involving the urinary system

1.98

1.09

1.9

2.0

—

Disorders of the thyroid gland

1.93

1.08

2.0

—

Conjunctivitis

1.96

1.07

2.0

—

Substance abuse

2.17

1.07

2.0

—

Other obstetric conditions, not elsewhere classified

2.43

1.05

2.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.42

1.05

2.0

—

Bacterial infection, other or unspecified, including avohilmo

2.12

1.05

2.0

—

Anxiety (asthma-related co-morbidities)

2.13

1.04

2.0

—

Disturbances of skin sensation

2.27

1.03

2.0

—

Other systemic involvement of connective tissue

2.27

1.03

2.0

—

Lyme disease

2.27

1.03

2.0

—

Lyme disease, including avohilmo

2.27

1.03

2.0

—

Other spirochaetal diseases

2.27

1.03

2.0

—

Diseases of liver

2.27

1.03

2.0

—

Dermatitis

2.07

1.03

2.0

—

Mental and behavioural disorders due to psychoactive substance use

2.07

1.03

2.0

—

Septicaemia

2.28

1.02

2.0

—

Other functional intestinal disorders

2.27

1.02

2.0

—

Procreative management

2.29

1.02

2.0

—

Polycystic ovarian syndrome, consortium definition

1.91

1.01

2.0

—

2.03

1.00

2.0

—

All anxiety disorders

2.01

0.99

2.0

—

Coxarthrosis, primary, with hip surgery

2.21

0.99

2.0

—

Complications of procedures, not elsewhere classified

1.86

0.99

2.0

—

Spirochaetal infections, other/unspecified, including avohilmo

2.17

0.98

2.0

—

Other spirochaetal diseases, including avohilmo

2.17

0.98

2.0

—

Hypothyroidism, other/unspecified

1.85

0.98

2.0

—

Excessive attrition of teeth

1.92

0.95

2.0

—

Type 2 diabetes, strict (exclude DM1)

1.83

0.93

1.9

2.0

—

Type 2 diabetes, definitions combined

1.83

0.93

1.9

2.0

—

Urinary track infection

2.00

0.92

2.0

—

Coxarthrosis, primary

2.16

0.92

2.0

—

Type 2 diabetes

1.82

0.91

1.9

2.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.81

0.91

1.9

2.0

—

Hypertension, essential

1.88

0.91

2.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.77

0.91

2.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.11

0.90

2.0

—

Concussion

2.11

0.90

2.0

—

Artificial joint operation, meniscal resection

1.83

0.86

2.0

—

Neurological diseases

1.86

0.86

2.0

—

Spontaneous abortion

2.01

0.86

2.0

1.9

—

Mental and behavioural disorders due to alcohol

1.97

0.85

2.0

—

Alcohol use disorder, Swedish definition

1.95

0.84

2.0

—

Other and unspecified dermatitis

1.94

0.84

2.0

—

Bacterial infection, other or unspecified

1.95

0.84

2.0

—

Insulin, intermediate and long-acting

1.93

0.84

1.8

2.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.77

0.83

2.0

—

Diabetic retinopathy, excluding more controls

0.00

0.83

0.0

1.9

—

Disorders of lacrimal system

1.90

0.83

2.0

—

Persons encountering health services in other circumstances, wide

1.71

0.82

2.0

—

Diabetic retinopathy

0.00

0.82

0.0

1.9

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.78

0.82

1.9

2.0

—

Triptan medication for migraine, single purchase ok

1.78

0.82

1.9

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1.77

0.81

2.0

—

Caries of enamel

1.71

0.80

2.0

—

Bacterial pneumoniae

0.00

0.80

0.0

2.0

—

Glaucoma suspect

0.00

0.79

0.0

2.0

—

Symptoms and signs involving speech and voice

0.00

0.79

0.0

2.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.76

0.79

2.0

—

Intracranial trauma

1.84

0.78

2.0

—

Abnormalities of breathing

1.77

0.78

2.0

—

Mood disorders, excluding more controls

1.76

0.78

2.0

—

Gonarthrosis,primary

1.75

0.77

2.0

—

1.79

0.77

2.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.73

0.77

2.0

—

Certain infectious and parasitic diseases, including avohilmo

1.95

0.76

2.0

—

Delivery

2.20

0.76

2.0

—

Renal failure

2.13

0.75

2.0

—

Other anxiety disorders

2.13

0.75

2.0

—

Dyspnoea

1.66

0.74

2.0

—

Systemic connective tissue disorders

2.08

0.74

2.0

—

Disorders of eyelid, lacrimal system and orbit

1.65

0.74

2.0

—

Gonarthrosis, primary, with knee surgery

2.05

0.73

2.0

—

Necrosis of pulp, including avohilmo

1.77

0.72

1.9

2.0

—

Chronic apical periodontitis

1.67

0.71

1.9

2.0

—

Other disorders of lacrimal gland

1.92

0.70

2.0

—

Acute appendicitis

1.71

0.70

2.0

—

Explicit Sepsis

1.90

0.69

2.0

—

In situ neoplasms

1.85

0.68

2.0

—

Alcohol use disorder, ICD-based

1.85

0.68

2.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.84

0.68

2.0

—

Appendicitis, broad definition

1.65

0.67

2.0

—

Diseases of appendix

1.65

0.67

2.0

—

Atopic dermatitis, strict definition

1.81

0.67

2.0

—

Influenza and pneumonia

1.61

0.66

2.0

—

Nerve, nerve root and plexus disorders

1.61

0.65

2.0

—

Carpal tunnel syndrome

1.60

0.65

2.0

—

Sleep disorders

1.64

0.64

2.0

—

Explicit Sepsis, including avohilmo

1.74

0.64

2.0

—

Contraceptive management

1.75

0.64

2.0

—

Diabetes, insulin treatment (Kela reimbursement)

1.60

0.63

1.9

2.0

—

Diseases of oesophagus, stomach and duodenum

1.64

0.63

2.0

—

Other disorders of veins

1.70

0.62

2.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.62

0.62

2.0

—

Implicit Sepsis, including avohilmo

1.63

0.62

2.0

—

Open wound of head

1.68

0.61

2.0

—

Malignant neoplasm of digestive organs

0.00

0.61

0.0

2.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.58

0.61

2.0

—

Asthma (only as main-diagnosis), excluding more controls

1.84

0.60

2.0

—

Benzodiazepine use

1.61

0.60

2.0

—

Anomalies of dental arch relationship, including avohilmo

0.00

0.60

0.0

2.0

—

Injuries to the knee and lower leg

1.54

0.60

2.0

—

Superficial injury of wrist and hand

0.00

0.60

0.0

2.0

—

Pedal cyclist injured in transport accident

0.00

0.60

0.0

2.0

—

Fracture of foot, except ankle

0.00

0.60

0.0

2.0

—

Malignant neoplasm of digestive organs, including Hilmo

0.00

0.60

0.0

2.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.60

0.0

2.0

—

Thyrotoxicosis

0.00

0.60

0.0

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.54

0.59

2.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.00

0.59

0.0

2.0

—

Bacterial pneumonia, not elsewhere classified

0.00

0.59

0.0

2.0

—

Asthma (only as main-diagnosis)

1.76

0.59

2.0

—

Impacted teeth

0.00

0.59

0.0

2.0

—

Pneumonias (Asthma/COPD co-morbidities)

1.59

0.58

2.0

—

Insulin medication

1.72

0.58

1.8

2.0

—

Insomnia

1.58

0.57

2.0

—

All pneumoniae

1.58

0.57

2.0

—

Diseases of arteries, arterioles and capillaries

1.69

0.57

2.0

—

Intracranial injury

1.69

0.57

2.0

—

Other (not insulin) diabetes medications

1.59

0.56

1.9

2.0

—

Asthma (mode)

1.66

0.56

2.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.65

0.56

1.8

2.0

—

Sleep apnoea

1.49

0.54

2.0

—

Complications of labour and delivery

1.59

0.54

2.0

—

Mycoses, including avohilmo

1.49

0.54

2.0

—

Dental pulpitis, including avohilmo

1.48

0.54

1.9

2.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.48

0.54

1.9

2.0

—

All kidney diseases

1.47

0.54

2.0

—

Other maternal disorders predominantly related to pregnancy

1.56

0.53

2.0

—

Sleep apnoea, including avohilmo

1.55

0.53

2.0

—

Missing teeth due to accident, extraction or parodontitis

1.49

0.51

2.0

—

Pregnancy with abortive outcome

1.58

0.50

2.0

—

Complications of medical and surgical care

1.53

0.48

2.0

—

Symptoms and signs involving the skin and subcutaneous tissue

1.50

0.48

2.0

—

Implicit Sepsis

1.47

0.47

2.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.72

0.45

2.0

1.9

—

Injuries to the shoulder and upper arm

1.47

0.43

2.0

—

Temporomandibular joint disorders, including avohilmo

1.61

0.43

2.0

—

Periapical abscess

1.61

0.43

2.0

—

Erysipelas

1.60

0.43

2.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.60

0.42

2.0

—

Provisional assignment of new diseases of uncertain etiology

1.55

0.42

2.0

—

Codes for special purposes

1.55

0.42

2.0

—

Colorectal cancer, including Hilmo

0.00

0.41

0.0

2.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.41

0.0

2.0

—

Unspecified acute lower respiratory infection

0.00

0.41

0.0

2.0

—

Scabies, including avohilmo

0.00

0.41

0.0

2.0

—

Alcohol dependence

0.00

0.41

0.0

2.0

—

Sulfonylureas

0.00

0.41

0.0

2.0

—

Blepharochalasis

0.00

0.40

0.0

2.0

—

All chronic kidney diseases

1.48

0.40

2.0

—

Acute appendicitis, no complications

1.46

0.40

2.0

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.40

0.0

2.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

0.00

0.40

0.0

2.0

—

Ventral hernia

0.00

0.40

0.0

2.0

—

Voice disturbances

0.00

0.40

0.0

2.0

—

Unspecified fall

1.44

0.39

2.0

—

Migraine

1.44

0.39

1.8

2.0

—

Chronic lower respiratory diseases

1.41

0.39

2.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.43

0.39

2.0

—

Asthma, excluding more controls

1.43

0.39

2.0

—

L04AA Selective immunosuppressants

0.00

0.39

0.0

2.0

—

Pediculosis, acariasis and other infestations, including avohilmo

0.00

0.39

0.0

2.0

—

Bronchitis

1.43

0.38

2.0

—

Mood [affective] disorders

1.31

0.37

2.0

—

Mood disorders

1.31

0.37

2.0

—

Selective serotonin reuptake inhibitors

1.30

0.37

2.0

—

Disorders of sclera, cornea, iris and ciliary body

1.35

0.37

2.0

—

Leiomyoma of uterus

1.40

0.35

2.0

—

Erysipelas, including avohilmo

1.39

0.35

2.0

—

Cholecystectomy

1.38

0.34

2.0

—

Inflammatory diseases of female pelvic organs

1.37

0.34

2.0

—

Other disorders of urethra and urinary system

1.35

0.34

2.0

—

Emergency coronary revascularization (for ACS)

1.36

0.32

2.0

—

Bleeding

1.36

0.31

2.0

—

Exposure to other specified factors

1.25

0.29

2.0

—

Diseases of the eye and adnexa

1.34

0.29

2.0

—

Other diseases of urinary system

1.32

0.29

2.0

—

Disorders of gallbladder, biliary tract and pancreas

1.28

0.28

2.0

—

Depression

1.24

0.27

2.0

—

Periodontitis

0.69

0.27

2.0

—

Chronic periodontitis, including avohilmo

0.69

0.27

2.0

—

Other antidepressants

1.28

0.26

2.0

—

Use of hypnotics and sedatives

1.29

0.26

2.0

—

Persons encountering health services for specific procedures and health care

0.74

0.25

2.0

—

Asthma

1.36

0.24

2.0

—

Cardiac arrhythmias

1.33

0.23

2.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.34

0.23

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.32

0.23

2.0

—

Dermatophytosis, including avohilmo

1.26

0.22

2.0

—

Allergic conjunctivitis

1.23

0.22

2.0

—

Hypertensive Heart Disease

0.00

0.22

0.0

2.0

—

Diabetic nephropathy, excluding more controls

0.00

0.21

0.0

2.0

—

Hypertensive heart and/or renal disease

0.00

0.21

0.0

2.0

—

Deep bite

0.00

0.21

0.0

2.0

—

Non-invasive ventilation

0.00

0.21

0.0

2.0

—

Wet age-related macular degeneration

0.00

0.21

0.0

2.0

—

Childhood allergy (age < 16)

0.00

0.21

0.0

2.0

—

Asthma, hospital admission 2, infections

1.19

0.21

2.0

—

Asthma-related infections

1.19

0.21

2.0

—

Phobic anxiety disorders

0.00

0.21

0.0

2.0

—

Postprocedural disorders of nervous system

0.00

0.21

0.0

2.0

—

Presbyopia

0.00

0.21

0.0

2.0

—

Other congenital malformations of skin, including avohilmo

0.00

0.21

0.0

2.0

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

2.0

—

Aortic valve malfunction, age under 60 years

0.00

0.21

0.0

2.0

—

Neuromuscular dysfunction of bladder

0.00

0.21

0.0

2.0

—

Infectious mononucleosis

0.00

0.21

0.0

2.0

—

Infectious mononucleosis, including avohilmo

0.00

0.21

0.0

2.0

—

Persons encountering health services for specific procedures, not carried out

0.00

0.21

0.0

2.0

—

Disorders of optic nerve and visual pathways

0.00

0.21

0.0

2.0

—

Brachial plexus disorders

0.00

0.21

0.0

2.0

—

0.00

0.21

0.0

2.0

—

Sequelae of injuries of upper limb

0.00

0.21

0.0

2.0

—

Inguinal hernia, bilateral

0.00

0.21

0.0

2.0

—

Embedded teeth, including avohilmo

0.00

0.21

0.0

2.0

—

Inguinal or femoral hernia, bilateral

0.00

0.21

0.0

2.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.21

0.0

2.0

—

Postpartum haemorrhage due to anatomy

0.00

0.21

0.0

2.0

—

Congenital malformations of genital organs

0.00

0.21

0.0

2.0

—

Otitis externa, unspecified

0.00

0.21

0.0

2.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.21

0.0

2.0

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

2.0

—

Other disorders of bladder

0.00

0.21

0.0

2.0

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

2.0

—

Retinal detachment with retinal break

0.00

0.21

0.0

2.0

—

Other embolism and thrombosis

0.00

0.21

0.0

2.0

—

Diplopia

0.00

0.21

0.0

2.0

—

Superficial injury of ankle and foot

0.00

0.21

0.0

2.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.21

0.0

2.0

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

0.00

0.21

0.0

2.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.21

0.0

2.0

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

2.0

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

2.0

—

Other inflammation of eyelid

0.00

0.21

0.0

2.0

—

Other female pelvic inflammatory diseases

0.00

0.21

0.0

2.0

—

Unspecified lump in breast

0.00

0.21

0.0

2.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.21

0.0

2.0

—

L02BA Anti-estrogens

0.00

0.21

0.0

2.0

—

Myocardial infarction, with ST-elevation

0.00

0.21

0.0

2.0

—

Superficial injury of thorax

0.00

0.21

0.0

2.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

0.21

0.0

2.0

—

Pain in thoracic spine

0.00

0.21

0.0

2.0

—

Other respiratory diseases principally affecting the interstitium

0.00

0.21

0.0

2.0

—

Radiculopathy

0.00

0.21

0.0

2.0

—

Benign neoplasm: Rectum

0.00

0.21

0.0

2.0

—

Cardiomyopathy

0.00

0.21

0.0

2.0

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.21

0.0

2.0

—

Other diseases of the respiratory system

0.00

0.21

0.0

2.0

—

Other respiratory disorders and diseases

0.00

0.21

0.0

2.0

—

Diabetic nephropathy

0.00

0.21

0.0

2.0

—

Diabetic maculopathy

0.00

0.21

0.0

2.0

—

Disorders of psychological development

0.00

0.21

0.0

2.0

—

Early lumbar disc prolapse operation

0.00

0.21

0.0

2.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.21

0.0

2.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.21

0.0

2.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

2.0

—

Dermatophytosis

0.00

0.21

0.0

2.0

—

Other metabolic disorders

0.00

0.21

0.0

2.0

—

0.00

0.21

0.0

2.0

—

Ectopic pregnancy

0.00

0.21

0.0

2.0

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

2.0

—

Acute laryngitis and tracheitis

0.00

0.21

0.0

2.0

—

Colorectal cancer

0.00

0.21

0.0

2.0

—

Perineal laceration during delivery

0.00

0.21

0.0

2.0

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

2.0

—

Lichen planus, including avohilmo

0.00

0.21

0.0

2.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.21

0.0

2.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

2.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.20

0.0

2.0

—

Poor fetal growth

0.00

0.20

0.0

2.0

—

Schizophrenia

0.00

0.20

0.0

2.0

—

Aneurysms, operations, SAH

0.00

0.20

0.0

2.0

—

Thyrotoxicosis, other and/or unspecified

0.00

0.20

0.0

2.0

—

severe traumatic brain injury, does not include concussion

0.00

0.20

0.0

2.0

—

Diabetic retinopathy, strict definition

0.00

0.20

0.0

2.0

—

Calcific aortic valvular stenosis, operated

0.00

0.20

0.0

2.0

—

Calcific aortic valvular stenosis

0.00

0.20

0.0

2.0

—

Operations 2 for CAVS

0.00

0.20

0.0

2.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.20

0.0

2.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.20

0.0

2.0

—

Other intervertebral disc disorders

1.19

0.20

2.0

—

Injuries to the ankle and foot

1.16

0.19

2.0

—

Dentofacial anomalies [including malocclusion]

1.14

0.19

2.0

—

Malignant neoplasm

1.21

0.18

2.0

—

Malignant neoplasm

1.21

0.18

2.0

—

Malignant neoplasm, including Hilmo

1.20

0.18

2.0

—

Malignant neoplasm, wide definition

1.20

0.18

2.0

—

Constipation

1.18

0.18

2.0

—

Asthma (diagnoses ohter than nonallergic)

1.18

0.18

2.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.20

0.17

2.0

—

Heart failure, not strict

1.16

0.10

2.0

—

Triptan medication for migraine, min. 3 purchases

1.13

0.10

1.8

2.0

—

Other arrhythmias

1.13

0.10

2.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.08

0.09

2.0

—

Cystitis

1.11

0.09

2.0

—

Renal tubulo-interstitial diseases

1.13

0.09

2.0

—

Cholelithiasis

1.11

0.09

2.0

—

Asthma, hospital admissions , main diagnosis only

1.09

0.09

2.0

—

Other disorders of ear

1.10

0.08

2.0

—

Biguanides

1.08

0.08

1.9

2.0

—

Asthma, including avohilmo

0.82

0.07

2.0

—

Other congenital malformations of the digestive system

0.00

0.0

2.0

—

Alcohol withdrawal state with delirium

0.00

0.0

2.0

—

Non-small cell lung cancer

0.00

0.0

2.0

—

Malignant neoplasm of head and neck

0.00

0.0

2.0

—

Malignant neoplasm of thyroid gland

0.00

0.0

2.0

—

Cholelithiasis, broad definition with cholecystitis

0.90

0.00

2.0

—

Haemolytic anaemias

0.00

0.0

2.0

—

Other specified and unspecified personality disorders

0.00

0.0

2.0

—

Corneal scars and opacities

0.00

0.0

2.0

—

ILD, hospital admissions 1, main diag only

0.00

0.0

2.0

—

Other diseases of stomach and duodenum

0.00

0.0

2.0

—

L02BB Anti-androgens

0.00

0.0

2.0

—

Ingrowing nail

0.00

0.0

2.0

—

Lung cancer and mesothelioma

0.00

0.0

2.0

—

All dysplastic lesions of the vagina

0.00

0.0

2.0

—

Chronic tubulo-interstitial nephritis

0.00

0.0

2.0

—

Polyhydramnios

0.00

0.0

2.0

—

Right hemicolectomy

0.00

0.0

2.0

—

Abnormalities of gait and mobility

0.00

0.0

2.0

—

L04AC Interleukin inhibitors

0.00

0.0

2.0

—

Sequelae of injuries of lower limb

0.00

0.0

2.0

—

Other and unspecified intracranial injuries

0.00

0.0

2.0

—

Open wound of ankle and foot

0.00

0.0

2.0

—

Other and unspecified injuries of ankle and foot

0.00

0.0

2.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.0

2.0

—

Adjustment and management of implanted device

0.00

0.0

2.0

—

0.00

0.0

2.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.0

2.0

—

Personal history of malignant neoplasm

0.00

0.0

2.0

—

Other orthopaedic follow-up care

0.00

0.0

2.0

—

Other pulmonary heart/vessel disease

0.00

0.0

2.0

—

Other vitreous opacities

0.00

0.0

2.0

—

Immunodeficiency with predominantly antibody defects

0.00

0.0

2.0

—

Benign neoplasm: Skin, unspecified

0.00

0.0

2.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.0

2.0

—

Congenital ovarian cysts

0.00

0.0

2.0

—

Memory loss

0.00

0.0

2.0

—

ILD, hospital admissions

0.00

0.0

2.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.97

0.00

2.0

—

Left bundle-branch block

0.00

0.0

2.0

—

Vestibular neuronitis

0.00

0.0

2.0

—

Nasal polyp

0.00

0.0

2.0

—

Non-small cell lung cancer, including Hilmo

0.00

0.0

2.0

—

Vascular dementia

0.00

0.0

2.0

—

Benign neoplasm: Caecum

0.00

0.0

2.0

—

Malignant neoplasm of pancreas, including Hilmo

0.00

0.0

2.0

—

Obsessive-compulsive disorder

0.00

0.0

2.0

—

Disorders of choroid and retina

0.95

0.00

2.0

—

Chalazion

0.00

0.0

2.0

—

Visual impairment including blindness (binocular or monocular)

0.00

0.0

2.0

—

Ulcerative ileocolitis

0.00

0.0

2.0

—

Other noninfective disorders of lymphatic vessels and lymph nodes

0.00

0.0

2.0

—

Fibrosis and cirrhosis of liver

0.00

0.0

2.0

—

Other epidermal thickening

0.00

0.0

2.0

—

Glaucoma, exfoliation

0.00

0.0

2.0

—

Pericarditis

0.00

0.0

2.0

—

Asthma/COPD (KELA code 203)

0.98

0.00

2.0

—

Hydronephrosis

0.00

0.0

2.0

—

Other appendicitis

0.00

0.0

2.0

—

Lichen simplex chronicus

0.00

0.0

2.0

—

Lichen simplex chronicus and prurigo

0.00

0.0

2.0

—

Allergic urticaria

0.00

0.0

2.0

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.0

2.0

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

0.0

2.0

—

Viral conjunctivitis, including avohilmo

0.00

0.0

2.0

—

Parkinson's disease

0.00

0.0

2.0

—

Urethral stricture

0.00

0.0

2.0

—

Lymphoid leukaemia

0.00

0.0

2.0

—

Ankylosing spondylitis, strict definition

0.00

0.0

2.0

—

Mixed hyperlipidaemia

0.00

0.0

2.0

—

Hypercalcemia

0.00

-0.00

0.0

2.0

—

Algoneurodystrophy

0.00

-0.00

0.0

2.0

—

Femoral hernia

0.00

-0.00

0.0

2.0

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

2.0

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Dissociative [conversion] disorders

0.00

-0.00

0.0

2.0

—

Congenital malformations and deformations of the musculoskeletal system

0.00

-0.00

0.0

2.0

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

2.0

—

Conductive and sensorineural hearing loss

1.01

-0.00

2.0

—

Schizoaffective disorder

0.00

-0.00

0.0

2.0

—

Other diseases of intestine

0.00

-0.00

0.0

2.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

2.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

-0.00

0.0

2.0

—

Crossbite

0.00

-0.00

0.0

2.0

—

Benign neoplasm of eye and adnexa

0.00

-0.00

0.0

2.0

—

Other interstitial pulmonary diseases

0.00

-0.00

0.0

2.0

—

Hypertrophic cardiomyopathy

0.00

-0.00

0.0

2.0

—

Other congenital malformations of the digestive system, including avohilmo

0.00

-0.00

0.0

2.0

—

Bacterial, viral and other infectious agents

0.00

-0.00

0.0

2.0

—

Pneumonia due to Streptococcus pneumoniae

0.00

-0.00

0.0

2.0

—

Other peripheral vertigo

0.00

-0.00

0.0

2.0

—

Lichen planus

0.00

-0.00

0.0

2.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

2.0

—

Astigmatism

0.00

-0.00

0.0

2.0

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Other neurotic disorders

0.00

-0.00

0.0

2.0

—

Other and unspecified mononeuropathies of upper limb

0.00

-0.00

0.0

2.0

—

Other specified/unspecified disorders of bone/cartilage

0.00

-0.00

0.0

2.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

2.0

—

Injuries to the wrist and hand

0.97

-0.00

2.0

—

Other specified and unspecified retinal disorders

0.00

-0.00

0.0

2.0

—

Other diseases of pericardium

0.00

-0.00

0.0

2.0

—

Pterygium

0.00

-0.00

0.0

2.0

—

Other renal tubulo-interstitial diseases

0.00

-0.00

0.0

2.0

—

Other disorders of adrenal gland

0.00

-0.00

0.0

2.0

—

Interstitial lung disease

0.00

-0.00

0.0

2.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

2.0

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

2.0

—

Other specified disorders of kidney and ureter

0.00

-0.00

0.0

2.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

2.0

—

Gingivitis and periodontal diseases

1.00

-0.00

2.0

—

Cholangitis (primary sclerosing, PSC)

0.00

-0.00

0.0

2.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

2.0

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

2.0

—

Spontaneous rupture of synovium and tendon

0.00

-0.00

0.0

2.0

—

Acidosis

0.00

-0.00

0.0

2.0

—

Disorders resulting from impaired renal tubular function

0.00

-0.00

0.0

2.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

2.0

—

Right bundle-branch block

0.00

-0.00

0.0

2.0

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

2.0

—

Contact with machinery

0.00

-0.00

0.0

2.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

2.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

2.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

0.95

-0.00

2.0

—

Graves disease, strict definition

0.00

-0.00

0.0

2.0

—

Other specified/unspecified hearing loss

0.00

-0.00

0.0

2.0

—

SLE, strict definition

0.00

-0.00

0.0

2.0

—

Diabetic neuropathy

0.00

-0.00

0.0

2.0

—

Chondromalacia

0.00

-0.00

0.0

2.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

2.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

2.0

—

Other surgical follow-up care

0.00

-0.00

0.0

2.0

—

Artificial opening status

0.00

-0.00

0.0

2.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Yersinia sp IgM Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS